Sponsored by

NovoCure Trial

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 4151 to 4175 of about 5880

Previous 25

Website Changes

11/22/2006

Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts

11/22/2006

The course of neurocognitive functioning in high-grade glioma patients

11/22/2006

Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol)

11/22/2006

The pathophysiologic mechanism of cerebellar mutism.

11/21/2006

University Evaluates New Device To Treat Brain Tumors

11/20/2006

Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting

11/20/2006

NEOPHARM AnNOUNCES Presentation of FINAL SAFETY DATA FROM PHASE 1 TRIAL OF CINTREDEKIN BESUDOTOX for Newly Diagnosed Malignant Glioma

11/19/2006

Celtic Pharma and Neurobiological Technologies Present an Update on XERECEPT(R) for Peritumoral Brain Edema at the 11th Annual Meeting of the Society For Neuro-Oncology

11/18/2006

Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer

11/18/2006

NCI Best Case Series for CAM: Outcomes in Treatment of Brain Tumors

11/18/2006

Vaccine for brain tumors shows promising results

11/10/2006

Reata Announces Presentation of Interim Results for Phase 1 Study of RTA 744 in Treatment of Advanced Brain Tumors

11/10/2006

Anti-cancer virus kills brain cancer cells

11/10/2006

Jefferson Oncologists Show Less Radiation Just as Effective in Fighting Brain Tumor, Saving Hearing

11/10/2006

A lesson in Living

11/10/2006

Northwest Biotherapeutics Discusses Results From Clinical Trials In Brain Cancer At Two Conferences

11/10/2006

Newly identified biomarker detects and regulates spread of brain tumors

11/10/2006

Neurospheres Enriched in Cancer Stem-Like Cells Are Highly Effective in Eliciting a Dendritic Cell-Mediated Immune Response against Malignant Gliomas.

11/10/2006

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.

11/10/2006

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.

11/10/2006

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial.

11/10/2006

Commercial flight and patients with intracranial mass lesions: a caveat. Report of two cases.

11/10/2006

Long-term response of pituitary carcinoma to temozolomide. Report of two cases.

11/10/2006

AACR Science Policy Alert

10/31/2006

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.

Our privacy / cookie policy has changed.
Click HERE to read it!